Compounds > tranylcypromine
Page last updated: 2024-08-22

tranylcypromine and 2-(2-benzofuranyl)-2-imidazoline

tranylcypromine has been researched along with 2-(2-benzofuranyl)-2-imidazoline in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steinberg, MI; Wiest, SA2
Chen, K; Pickard, RT; Shih, JC; Steinberg, MI; Wiest, SA1
Handley, SL; MacInnes, N1
Holt, A; McDonald, GR; Olivieri, A; Ramsay, RR1
Binda, C; Bonivento, D; Edmondson, DE; Holt, A; Mattevi, A; McDonald, GR; Milczek, EM1

Other Studies

6 other study(ies) available for tranylcypromine and 2-(2-benzofuranyl)-2-imidazoline

ArticleYear
Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
    Life sciences, 1997, Volume: 60, Issue:9

    Topics: Animals; Benzofurans; Binding, Competitive; Brain; Cerebral Cortex; Humans; Idazoxan; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Kinetics; Ligands; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Rats; Receptors, Drug; Reticular Formation; Tranylcypromine

1997
Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms.
    Annals of the New York Academy of Sciences, 1999, Jun-21, Volume: 881

    Topics: Animals; Benzofurans; Blood Platelets; Brain; Cell Membrane; Cerebral Cortex; Humans; Idazoxan; Imidazoles; Imidazoline Receptors; Isoenzymes; Kinetics; Ligands; Monoamine Oxidase; Rats; Receptors, Drug; Tranylcypromine; Tritium

1999
3H[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 360, Issue:2

    Topics: Affinity Labels; Benzofurans; Binding, Competitive; Blood Platelets; Dose-Response Relationship, Drug; Drug Interactions; Edetic Acid; Humans; Imidazoles; In Vitro Techniques; Intracellular Membranes; Ligands; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Time Factors; Tranylcypromine

1999
Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I(2) sites.
    European journal of pharmacology, 2001, Oct-05, Volume: 428, Issue:2

    Topics: Animals; Arcuate Nucleus of Hypothalamus; Benzofurans; Binding Sites; Binding, Competitive; Brain; Cerebellum; Cerebral Cortex; Dose-Response Relationship, Drug; Imidazoles; Imidazoline Receptors; Male; Monoamine Oxidase Inhibitors; Pineal Gland; Rats; Rats, Wistar; Receptors, Drug; Tranylcypromine; Tritium

2001
On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
    Pharmacological research, 2010, Volume: 62, Issue:6

    Topics: Allosteric Regulation; Benzofurans; Binding Sites; Humans; Imidazoles; Imidazoline Receptors; Ligands; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Mutation; Phenethylamines; Protein Binding; Recombinant Proteins; Tranylcypromine

2010
Potentiation of ligand binding through cooperative effects in monoamine oxidase B.
    The Journal of biological chemistry, 2010, Nov-19, Volume: 285, Issue:47

    Topics: Benzofurans; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Humans; Imidazoles; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Mutagenesis, Site-Directed; Protein Binding; Protein Conformation; Recombinant Proteins; Tranylcypromine

2010